pradaxa

The blood-thinning drug PRADAXA has been linked to fatal internal bleeding and heart attacks. The FDA approved Pradaxa in October 2010 and it is manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is used to treat atrial fibrillation, an irregular heartbeat that can increase a patient’s risk of stroke. A study published in the Archives of Internal Medicine in 2012 found that Pradaxa was “significantly associated with a higher risk” of heart attacks and acute coronary syndrome compared to the alternative wafarin.
Image: 
pradaxalawyerbloodthinninganticoagulantsideeffectslawsuitinfographic_51471b542b285.jpg

Category:

Language: 
English
Thumb Meta Data: 
pradaxalawyerbloodthinninganticoagulantsideeffectslawsuitinfographic_51471b542b285.jpg
Hash: 
e8c71e5e1aaa3997091f87af094cfb15
Reviewed: 
Source: 
http://www.good-legal-advice.com/pradaxa.htm
Infographic Type: 
Infographic
Visible on Site: 
Show in Portfolio: 
Marketplace Infographic: